We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-20.27%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
–
AUM
$613K
AUM Growth
-$694M
Cap. Flow
-$229M
Cap. Flow %
-37,377.98%
Top 10 Hldgs %
43.1%
Holding
965
New
6
Increased
47
Reduced
75
Closed
214

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$23.5M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$22.6M
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$18.8M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$14.3M
5
FBT icon
First Trust NYSE Arca Biotechnology Index Fund
FBT
+$14M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$49.3M
2
DTE icon
DTE Energy
DTE
+$17M
3
SBUX icon
Starbucks
SBUX
+$9.35M
4
BHF icon
Brighthouse Financial
BHF
+$8.94M
5
BNY
Bank of New York Mellon
BNY
+$8.69M

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Healthcare 9.04%
3 Financials 7.22%
4 Consumer Staples 6.76%
5 Consumer Discretionary 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCI icon
501
Rogers Communications
RCI
$18.9B
$6 ﹤0.01%
135
– –
RMBS icon
502
Rambus
RMBS
$9.62B
$6 ﹤0.01%
500
– –
ROKU icon
503
Roku
ROKU
$21.6B
$6 ﹤0.01%
110
– –
RY icon
504
Royal Bank of Canada
RY
$291B
$6 ﹤0.01%
100
– –
SGMO
505
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$6 ﹤0.01%
1,000
– –
SRE icon
506
Sempra
SRE
$58.3B
$6 ﹤0.01%
110
– –
STE icon
507
Steris
STE
$22.8B
$6 ﹤0.01%
40
– –
SVM
508
Silvercorp Metals
SVM
$2.09B
$6 ﹤0.01%
1,785
– –
TAK icon
509
Takeda Pharmaceutical
TAK
$56.9B
$6 ﹤0.01%
395
– –
TU icon
510
Telus
TU
$17.2B
$6 ﹤0.01%
400
-400
-50% -$7.41K
VRTX icon
511
Vertex Pharmaceuticals
VRTX
$124B
$6 ﹤0.01%
24
– –
XRX icon
512
Xerox
XRX
$362M
$6 ﹤0.01%
300
– –
ATCX
513
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$6 ﹤0.01%
740
– –
COR
514
DELISTED
Coresite Realty Corporation
COR
$6 ﹤0.01%
48
– –
CY
515
DELISTED
Cypress Semiconductor
CY
$6 ﹤0.01%
255
-88,445
-100% -$2.02M
A icon
516
Agilent Technologies
A
$39.7B
$5 ﹤0.01%
67
– –
APPN icon
517
Appian
APPN
$2.12B
$5 ﹤0.01%
132
– –
AXDX
518
DELISTED
Accelerate Diagnostics
AXDX
$5 ﹤0.01%
60
– –
BLUE
519
DELISTED
bluebird bio
BLUE
$5 ﹤0.01%
8
-103
-93% -$100K
BMO icon
520
Bank of Montreal
BMO
$125B
$5 ﹤0.01%
100
-2,301
-96% -$156K
CNI icon
521
Canadian National Railway
CNI
$78.8B
$5 ﹤0.01%
58
– –
CPB icon
522
Campbell Soup
CPB
$6.74B
$5 ﹤0.01%
100
– –
FCEL icon
523
FuelCell Energy
FCEL
$1.6B
$5 ﹤0.01%
105
– –
HWM icon
524
Howmet Aerospace
HWM
$113B
$5 ﹤0.01%
655
– –
IBN icon
525
ICICI Bank
IBN
$108B
$5 ﹤0.01%
573
– –
19 20
21
22 23

Similar funds

BFA
Brendel Financial Advisors Hanover, New Hampshire $202M AUM 37.99% 1-Year Est. Return
PCMK
Paragon Capital Management (Kansas) Overland Park, Kansas $202M AUM 26.44% 1-Year Est. Return
AFWM
Arta Finance Wealth Management Mountain View, California $202M AUM
PCM
Pointe Capital Management Grosse Pointe Farms, Michigan $202M AUM 17.2% 1-Year Est. Return
IFU
iSAM Funds (UK) London, United Kingdom $203M AUM 18.34% 1-Year Est. Return
MFG
Marmo Financial Group Johnson City, Tennessee $202M AUM 13.32% 1-Year Est. Return
GW
Griffith & Werner Canton, Georgia $202M AUM
RA
Riverstone Advisors New Braunfels, Texas $203M AUM 27.33% 1-Year Est. Return

tru Independence's Q1 2020 Portfolio in Review

As of Q1 2020, tru Independence held 965 positions worth $613K, down 100% from $695M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

tru Independence withdrew a net $229M in Q1 2020, closing 214 positions and reducing 75 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, tru Independence opened a new position in Norbord Inc. worth $3.02K.

  • tru Independence's largest Q1 2020 buy was Norbord Inc.: 254,795 shares worth $3.02K.
  • tru Independence added most to State Street SPDR S&P Biotech ETF in Q1 2020, an estimated $23.5M increase.
  • tru Independence's biggest Q1 2020 reduction was DTE Energy, cutting an estimated $17M.
  • tru Independence fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $49.3M.
  • tru Independence's ten largest holdings make up 43% of its $613K portfolio in Q1 2020.
  • tru Independence opened 6 new positions and closed 214 in Q1 2020.
  • tru Independence's portfolio value fell 100% quarter-over-quarter to $613K.

Based on tru Independence's 13F filing for Q1 2020, filed 19 May 2020.